Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Crowe

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapyRahul D Tendulkar, Sana Rehman, Monica E Shukla, et al.
Annals of Surgical Oncology|August 17, 2016
Erratum to: Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and OutcomesDevina K S McCray, Ashley B Simpson, Rebecca Flyckt, et al.
Annals of Surgical Oncology|June 24, 2016
Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and OutcomesDevina K S McCray, Ashley B Simpson, Rebecca Flyckt, et al.
Human Pathology|May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization studyDavid G Hicks, Brian J Yoder, James Pettay, et al.
Cancer Research|March 17, 2006
In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopyAbigail S Haka, Zoya Volynskaya, Joseph A Gardecki, et al.
Breast (Edinburgh, Scotland)|May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institutionJoseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
Journal of Surgical Oncology|July 13, 2017
Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapyCraig A Wengler, Stephanie A Valente, Zahraa Al-Hilli, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 29, 2007
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experienceRaymond R Tubbs, David G Hicks, James Cook, et al.
The Breast Journal|February 27, 2007
The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical studySarah M Short, Brian J Yoder, Shannon M Tarr, et al.
The American Journal of Surgical Pathology|August 26, 2006
Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFRDavid G Hicks, Sarah M Short, Nichole L Prescott, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapyRahul D Tendulkar, Sana Rehman, Monica E Shukla, et al.
Annals of Surgical Oncology|August 17, 2016
Erratum to: Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and OutcomesDevina K S McCray, Ashley B Simpson, Rebecca Flyckt, et al.
Annals of Surgical Oncology|June 24, 2016
Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and OutcomesDevina K S McCray, Ashley B Simpson, Rebecca Flyckt, et al.
Human Pathology|May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization studyDavid G Hicks, Brian J Yoder, James Pettay, et al.
Cancer Research|March 17, 2006
In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopyAbigail S Haka, Zoya Volynskaya, Joseph A Gardecki, et al.
Breast (Edinburgh, Scotland)|May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institutionJoseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
Journal of Surgical Oncology|July 13, 2017
Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapyCraig A Wengler, Stephanie A Valente, Zahraa Al-Hilli, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 29, 2007
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experienceRaymond R Tubbs, David G Hicks, James Cook, et al.
The Breast Journal|February 27, 2007
The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical studySarah M Short, Brian J Yoder, Shannon M Tarr, et al.
The American Journal of Surgical Pathology|August 26, 2006
Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFRDavid G Hicks, Sarah M Short, Nichole L Prescott, et al.
Pageof 5